Discontinuing insulin for older adults with type 2 diabetes

insulin
Credit: CC0 Public Domain

Patients with type 2 diabetes who were in poor health were more likely to continue taking insulin after age 75 than their counterparts in better health, according to Kaiser Permanente research published today in JAMA Internal Medicine. As people with type 2 diabetes age, the risks of insulin use can outweigh its benefits, creating the need for increased provider and patient education.

"Leading medical specialty organizations recommend reducing diabetes treatment intensity for , particularly when they have multiple, life-limiting health conditions. But in we found that these sicker patients were less likely to stop taking insulin," said senior author Richard W. Grant, MD, MPH, research scientist with the Kaiser Permanente Division of Research in Oakland, California.

Insulin is a hormone that helps the body regulate sugar in the blood and is a key component of treatment for many patients with type 2 diabetes. Older adults who continue to use insulin are at greater risk of dangerously , or hypoglycemia; this can happen when people take too large a dose of insulin, Grant explained.

In the study "The Use and Discontinuation of Insulin Among Adults Aged 75-79 with Type 2 Diabetes: A Longitudinal Cohort Study," researchers followed 21,531 Kaiser Permanente members age 75 and older in Northern California who had type 2 diabetes. Nearly one-fifth of the patients used insulin at the beginning of the study, and among them, about one-third discontinued its use over the next 4 years.

The researchers grouped patients into three categories of health (poor, intermediate, and good) using information in the medical record about the number of chronic conditions, functional status, and indicators of end-stage disease. Insulin use was highest among in (29% of them used insulin) with a serious end-stage disease, or intermediate health (28% used insulin) with at least two other . In contrast, just 11% of those in good health used insulin. The findings were similar even when researchers took into account how well patients were controlling their blood sugar.

"Revisiting the need for potentially harmful medications such as insulin when the risks outweigh the benefits can help to reduce adverse events like hypoglycemia and improve the quality of care in older patients," Dr. Grant said.

Pharmacists, , geriatric specialists and others are working together to address "polypharmacy"—when older patients take 5 or more medications for multiple conditions—and to "de-prescribe" medications by reducing doses or taking people off them, he added.

A recent Kaiser Permanente study showed that discontinuing diabetes medications reduced the risk of hypoglycemia in elderly patients with well-controlled type 2 diabetes.

"We're raising awareness about the need for physicians and patients to have conversations and reconsider medications that may lose benefit or add more risk as patients age," said Maisha S. Draves, MD, medical director of pharmacy for The Permanente Medical Group at Kaiser Permanente in Northern California.


Explore further

Human insulin as safe and effective to treat type 2 diabetes as costlier insulin analogs

More information: JAMA Internal Medicine (2019). DOI: 10.1001/jamainternmed.2019.3759
Journal information: JAMA Internal Medicine

Provided by Kaiser Permanente
Citation: Discontinuing insulin for older adults with type 2 diabetes (2019, September 23) retrieved 18 October 2019 from https://medicalxpress.com/news/2019-09-discontinuing-insulin-older-adults-diabetes.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
5 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more